🇪🇺 BOTULINUM TOXIN TYPE B in European Union

BOTULINUM TOXIN TYPE B (BOTULINUM TOXIN TYPE B) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000301
  • Local brand name: NeuroBloc
  • Status: withdrawn

BOTULINUM TOXIN TYPE B in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BOTULINUM TOXIN TYPE B approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for BOTULINUM TOXIN TYPE B in European Union?

Eisai Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.